Home » Maaz Rafique

Maaz Rafique

Senior Analyst

Maaz Rafique was a Senior Analyst at CBPartners.

Connect with Maaz Rafique

maaz.rafique@cbpartners.com

LinkedIn

Published Articles

KYMRIAH and TRELEGY Become the First Drugs to Undergo Japan’s New CEA System

What can be learned from the first use of Japan's new Cost-Effectiveness Assessment (CEA) system? Read CBPartners' infographic here.

Applying Technology in Pharma (ATP): Assessment of Investment Trends in Digital Health

VC investment in digital healthcare has been growing rapidly (+42% vs. 2017) as the potential of new technology to solve complex issues, ranging from providing healthcare services to managing chronic conditions, evolves. CBPartners takes a look at investment trends in digital health.